ZOHAR DAPHNE enters SEAPORT THERAPEUTICS, INC. with 1.19M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 5/1/2026ACC: 0001193125-26-198531
DirectorOfficer· Chief Executive Officer
Since Apr 2026
1.19M
Baseline shares
100% direct
1.19M
Direct ownership
1 position
2.77M
Derivative underlying
3 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned1.19M
Total
1.19M direct1.19M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.19M | Direct |
| Total | 1.19M | 1.19M direct |
Derivative Holdings3
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
182.49K
Shares owned
N/A
Exercise price
7.39
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
271.81K
Shares owned
N/A
Exercise price
10.31
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
2.31M
Shares owned
N/A
Exercise price
3.05
Expiration
—
Exercise window
—
Total
Underlying
2.77M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 7.39 | — | — | 182.49K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 10.31 | — | — | 271.81K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 3.05 | — | — | 2.31M | N/A |
| Total | 2.77M | 0.00 | ||||